Jonathan Weiss / Shutterstock.com
Avid Radiopharmaceuticals, a subsidiary of Eli Lilly, has taken the Alzheimer's Institute of America (AIA) to court over its “malicious” prosecution of a patent infringement case.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Eli Lilly, Avid Radiopharmaceuticals, Alzheimer's Institute of America, malicious patent infringement, Alzheimer’s, Imperial College
